Kestra Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.16M | Sell |
55,547
-19,504
| -26% | -$2.16M | 0.03% | 544 |
|
|
2025
Q1 | $8.41M | Sell |
75,051
-11,583
| -13% | -$1.3M | 0.04% | 399 |
|
|
2024
Q4 | $8M | Buy |
86,634
+10,517
| +14% | +$971K | 0.04% | 418 |
|
|
2024
Q3 | $6.38M | Sell |
76,117
-18,070
| -19% | -$1.51M | 0.04% | 511 |
|
|
2024
Q2 | $6.05M | Buy |
94,187
+33,007
| +54% | +$2.12M | 0.03% | 525 |
|
|
2024
Q1 | $4.48M | Buy |
61,180
+6,316
| +12% | +$463K | 0.03% | 563 |
|
|
2023
Q4 | $4.44M | Buy |
54,864
+7,007
| +15% | +$568K | 0.04% | 498 |
|
|
2023
Q3 | $3.59M | Buy |
47,857
+8,417
| +21% | +$631K | 0.04% | 490 |
|
|
2023
Q2 | $3.04M | Sell |
39,440
-2,798
| -7% | -$216K | 0.03% | 540 |
|
|
2023
Q1 | $3.5M | Sell |
42,238
-41,261
| -49% | -$3.42M | 0.04% | 459 |
|
|
2022
Q4 | $7.17M | Buy |
83,499
+9,338
| +13% | +$802K | 0.06% | 325 |
|
|
2022
Q3 | $4.58M | Buy |
74,161
+6,585
| +10% | +$406K | 0.05% | 397 |
|
|
2022
Q2 | $4.18M | Buy |
67,576
+16,494
| +32% | +$1.02M | 0.04% | 406 |
|
|
2022
Q1 | $3.04M | Sell |
51,082
-24,530
| -32% | -$1.46M | 0.03% | 532 |
|
|
2021
Q4 | $5.49M | Buy |
75,612
+2,161
| +3% | +$157K | 0.06% | 340 |
|
|
2021
Q3 | $5.13M | Buy |
73,451
+18,542
| +34% | +$1.3M | 0.05% | 382 |
|
|
2021
Q2 | $3.78M | Buy |
54,909
+1,310
| +2% | +$90.2K | 0.04% | 438 |
|
|
2021
Q1 | $3.46M | Buy |
53,599
+1,460
| +3% | +$94.4K | 0.04% | 424 |
|
|
2020
Q4 | $2.95M | Buy |
52,139
+7,770
| +18% | +$440K | 0.03% | 468 |
|
|
2020
Q3 | $2.81M | Buy |
+44,369
| New | +$2.81M | 0.05% | 347 |
|